Abstract
Obesity is currently one of the most prevalent diseases on the planet. Unfortunately, behavioral approaches, which include increasing physical activity combined with reducing caloric intake, have a high rate of refractoriness, and in general, patients are unable to adhere to the recommendations for long periods. In the last decade, the introduction of glucagon-like peptide-1 receptor agon…